Impact of successful HCV treatment using direct acting antivirals on recurrence of well ablated hepatocellular carcinoma.

Tamer ElbazImam WakedWafaa El-AkelMohamed Kamal ShakerAshraf Omar AbdelazizMonkez YousifMahmoud El-BendarySamy ZakyMohamed AbdAllahMohamed HassanyGamal EsmatWahid Doss

Published in: Expert review of anti-infective therapy (2021)

Recurrence of HCC remains a threat in HCV patients even after achieving an SVR. Implementation of long-term surveillance programs is highly recommended.

Keyphrases

hepatitis c virus
end stage renal disease
public health
ejection fraction
newly diagnosed
primary care
chronic kidney disease
healthcare
human immunodeficiency virus
free survival
peritoneal dialysis
patient reported outcomes
hiv infected